Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q1 2025 · 10-Q
Revenue$34.72M$34.72M+8.5% vs Q1 2024 Net Income-$267.00K-$267.00KN/M vs Q1 2024 EPS Diluted-$0.01-$0.01N/M vs Q1 2024 Gross Profit$19,167,000+16.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flow$1,780,000+372.1% Free Cash Flowderived$1,649,000+745.6% Margins · derivedGross margin55.2%+3.7 pt vs Q1 2024
Operating margin1.8%+4.4 pt vs Q1 2024
Net margin-0.8%+2.7 pt vs Q1 2024
ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end